These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

647 related items for PubMed ID: 19938138

  • 21. Association of cytomegalovirus infection and disease with recurrent hepatitis C after liver transplantation.
    Bosch W, Heckman MG, Pungpapong S, Diehl NN, Shalev JA, Hellinger WC.
    Transplantation; 2012 Apr 15; 93(7):723-8. PubMed ID: 22406819
    [Abstract] [Full Text] [Related]

  • 22. Recurrent hepatitis C posttransplant: early preservation injury may predict poor outcome.
    Watt KD, Lyden ER, Gulizia JM, McCashland TM.
    Liver Transpl; 2006 Jan 15; 12(1):134-9. PubMed ID: 16382465
    [Abstract] [Full Text] [Related]

  • 23. Outcome of living donor liver transplantation for Egyptian patients with hepatitis C (genotype 4)-related cirrhosis.
    Yosry A, Esmat G, El-Serafy M, Omar A, Doss W, Said M, Abdel-Bary A, Hosny A, Marawan I, El-Malt O, Kamel RR, Hatata Y, Ghali A, Sabri H, Kamel S, El-Gbaly H, Tanaka K.
    Transplant Proc; 2008 Jun 15; 40(5):1481-4. PubMed ID: 18589133
    [Abstract] [Full Text] [Related]

  • 24. Histologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantation.
    Shiffman ML, Stravitz RT, Contos MJ, Mills AS, Sterling RK, Luketic VA, Sanyal AJ, Cotterell A, Maluf D, Posner MP, Fisher RA.
    Liver Transpl; 2004 Oct 15; 10(10):1248-55. PubMed ID: 15376308
    [Abstract] [Full Text] [Related]

  • 25. Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients.
    Berenguer M, Prieto M, San Juan F, Rayón JM, Martinez F, Carrasco D, Moya A, Orbis F, Mir J, Berenguer J.
    Hepatology; 2002 Jul 15; 36(1):202-10. PubMed ID: 12085366
    [Abstract] [Full Text] [Related]

  • 26. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
    Hayashi PH, Forman L, Steinberg T, Bak T, Wachs M, Kugelmas M, Everson GT, Kam I, Trotter JF.
    Liver Transpl; 2003 Jul 15; 9(7):737-40. PubMed ID: 12827562
    [Abstract] [Full Text] [Related]

  • 27. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
    de Arias AE, Haworth SE, Belli LS, Burra P, Pinzello G, Vangeli M, Minola E, Guido M, Boccagni P, De Feo TM, Torelli R, Cardillo M, Scalamogna M, Poli F.
    Liver Transpl; 2009 Apr 15; 15(4):390-9. PubMed ID: 19326408
    [Abstract] [Full Text] [Related]

  • 28. Comparison of hepatitis C histological recurrence rates and patient survival between split and deceased donor liver transplantation.
    Lawal A, Ghobrial R, Te H, Artinian L, Eastwood D, Schiano TD.
    Transplant Proc; 2007 Dec 15; 39(10):3261-5. PubMed ID: 18089367
    [Abstract] [Full Text] [Related]

  • 29. Liver transplantation for HCV-associated liver cirrhosis: predictors of outcomes in a population with significant genotype 3 and 4 distribution.
    Zekry A, Whiting P, Crawford DH, Angus PW, Jeffrey GP, Padbury RT, Gane EJ, McCaughan GW, Australian and New Zealand Liver Transplant Clinical Study Group.
    Liver Transpl; 2003 Apr 15; 9(4):339-47. PubMed ID: 12682883
    [Abstract] [Full Text] [Related]

  • 30. HCV histological recurrence and survival following liver transplantation in patients with and without hepatocellular carcinoma.
    De Martin E, Senzolo M, Boninsegna S, Guido M, Masier A, Germani G, Tomat S, Brolese A, Neri D, Cillo U, Gambato M, Russo FP, Farinati F, Burra P.
    Transplant Proc; 2008 Apr 15; 40(6):1974-5. PubMed ID: 18675104
    [Abstract] [Full Text] [Related]

  • 31. Early identification of recipients with progressive histologic recurrence of hepatitis C after liver transplantation.
    Sreekumar R, Gonzalez-Koch A, Maor-Kendler Y, Batts K, Moreno-Luna L, Poterucha J, Burgart L, Wiesner R, Kremers W, Rosen C, Charlton MR.
    Hepatology; 2000 Nov 15; 32(5):1125-30. PubMed ID: 11050065
    [Abstract] [Full Text] [Related]

  • 32. Transforming growth factor β1 polymorphisms and progression of graft fibrosis after liver transplantation for hepatitis C virus--induced liver disease.
    Eurich D, Bahra M, Boas-Knoop S, Lock JF, Golembus J, Neuhaus R, Neuhaus P, Neumann UP.
    Liver Transpl; 2011 Mar 15; 17(3):279-88. PubMed ID: 21384510
    [Abstract] [Full Text] [Related]

  • 33. Impact of donor age on survival and fibrosis progression in patients with hepatitis C undergoing liver transplantation using HCV+ allografts.
    Khapra AP, Agarwal K, Fiel MI, Kontorinis N, Hossain S, Emre S, Schiano TD.
    Liver Transpl; 2006 Oct 15; 12(10):1496-503. PubMed ID: 16964597
    [Abstract] [Full Text] [Related]

  • 34. The Tor Vergata weaning off immunosuppression protocol in stable HCV liver transplant patients: the updated follow up at 78 months.
    Orlando G, Manzia T, Baiocchi L, Sanchez-Fueyo A, Angelico M, Tisone G.
    Transpl Immunol; 2008 Nov 15; 20(1-2):43-7. PubMed ID: 18773958
    [Abstract] [Full Text] [Related]

  • 35. Comparative analysis of hepatitis C recurrence and fibrosis progression between deceased-donor and living-donor liver transplantation: 8-year longitudinal follow-up.
    Jain A, Singhal A, Kashyap R, Safadjou S, Ryan CK, Orloff MS.
    Transplantation; 2011 Aug 27; 92(4):453-60. PubMed ID: 21799468
    [Abstract] [Full Text] [Related]

  • 36. Hepatitis C.
    Burra P.
    Semin Liver Dis; 2009 Feb 27; 29(1):53-65. PubMed ID: 19235659
    [Abstract] [Full Text] [Related]

  • 37. A graft to body weight ratio less than 0.8 does not exclude adult-to-adult right-lobe living donor liver transplantation.
    Selzner M, Kashfi A, Cattral MS, Selzner N, Greig PD, Lilly L, McGilvray ID, Therapondos G, Adcock LE, Ghanekar A, Levy GA, Renner EL, Grant DR.
    Liver Transpl; 2009 Dec 27; 15(12):1776-82. PubMed ID: 19938139
    [Abstract] [Full Text] [Related]

  • 38. Plasma cell hepatitis in hepatitis C virus patients post-liver transplantation: case-control study showing poor outcome and predictive features in the liver explant.
    Ward SC, Schiano TD, Thung SN, Fiel MI.
    Liver Transpl; 2009 Dec 27; 15(12):1826-33. PubMed ID: 19938116
    [Abstract] [Full Text] [Related]

  • 39. Long-term outcome of hepatitis C infection after liver transplantation.
    Gane EJ, Portmann BC, Naoumov NV, Smith HM, Underhill JA, Donaldson PT, Maertens G, Williams R.
    N Engl J Med; 1996 Mar 28; 334(13):815-20. PubMed ID: 8596547
    [Abstract] [Full Text] [Related]

  • 40. Immunohistochemical staining of liver grafts with a monoclonal antibody against HCV-Envelope 2 for recurrent hepatitis C after living donor liver transplantation.
    Sadamori H, Yagi T, Iwagaki H, Matsuda H, Shinoura S, Umeda Y, Ohara N, Yanai H, Ogino T, Tanaka N.
    J Gastroenterol Hepatol; 2009 Apr 28; 24(4):574-80. PubMed ID: 19368635
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 33.